A study led by researchers from The University of Texas MD Anderson Cancer Center showed a significant overall survival benefit with ribociclib plus endocrine therapy for postmenopausal patients with hormone receptor-positive ...
Mar 9, 2022
0
11
Patients with two out of the three most common types of advanced breast cancer now have an average survival time of at least five years, according to a panel of experts at the Advanced Breast Cancer Sixth International Consensus ...
Nov 8, 2021
0
1
Patients with advanced breast cancer should receive COVID-19 vaccinations as soon as possible and the second dose should be delivered early, no later than three to four weeks after the first, the virtual meeting of the Advanced ...
Nov 5, 2021
0
18
Clinicians and the wider research community involved in treating advanced breast cancer (ABC) need to do more to help and encourage patients to join clinical trials, according to a patient advocate who is leading a study ...
Nov 4, 2021
0
1
The risk of early breast cancer spreading to another part of the body ranges from 6% to 22%, according to the first results of a large and detailed global study of metastatic breast cancer presented at the Advanced Breast ...
Nov 2, 2021
0
3
A simple blood test can identify specific genetic mutations in patients' breast tumors to help guide their treatment and assess how likely patients are to relapse, a study shows.
Nov 1, 2021
0
22
A mammogram is an X-ray image of your breasts that is used to screen for breast cancer. Mammograms play a key role in early breast cancer detection and help decrease breast cancer deaths.
Oct 18, 2021
0
13
In a first-in-human, Phase I trial, researchers at The University of Texas MD Anderson Cancer Center discovered that ATR inhibitor RP-3500 was safe and well tolerated with promising clinical benefit. Principal investigator ...
Oct 8, 2021
0
29
October is Breast Cancer Awareness Month, which makes this a good time to learn more about metastatic breast cancer.
Oct 6, 2021
0
4
Adding a CDK 4/6 inhibitor to first-line hormonal treatment prolongs survival by one year for postmenopausal women with hormone receptor (HR) positive, HER2 negative advanced breast cancer, according to late breaking results ...
Sep 20, 2021
0
0
